loadpatents
name:-0.017736911773682
name:-0.011393070220947
name:-0.0074870586395264
Sotomayor; Eduardo M. Patent Filings

Sotomayor; Eduardo M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sotomayor; Eduardo M..The latest application filed is for "histone deacetylase as a modulator of pdli expression and activity".

Company Profile
8.10.17
  • Sotomayor; Eduardo M. - Tampa FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Histone Deacetylase As A Modulator Of Pdli Expression And Activity
App 20220184047 - Villagra; Alejandro V. ;   et al.
2022-06-16
Histone Deacetylase 6 Inhibition For Enhancing T-cell Function During Anti-tumor Response And Tumor-peptide Vaccination
App 20220000867 - Sotomayor; Eduardo M. ;   et al.
2022-01-06
Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination
Grant 10,918,638 - Sotomayor , et al. February 16, 2
2021-02-16
Bromodomain inhibitor as adjuvant in cancer immunotherapy
Grant 10,813,939 - Sotomayor , et al. October 27, 2
2020-10-27
Histone Deacetylase As A Modulator Of Pdli Expression And Activity
App 20200188366 - Villagra; Alejandro V. ;   et al.
2020-06-18
Histone deacetylase as a modulator of PDLI expression and activity
Grant 10,576,066 - Villagra , et al.
2020-03-03
Histone Deacetylase As A Modulator Of Pdli Expression And Activity
App 20190298701 - VILLAGRA; Alejandro V. ;   et al.
2019-10-03
Histone Deacetylase As A Modulator Of Pdli Expression And Activity
App 20190192489 - VILLAGRA; Alejandro V. ;   et al.
2019-06-27
Selective histone deactylase 6 inhibitors
Grant 10,227,295 - Sotomayor , et al.
2019-03-12
Histone Deacetylase 6 Inhibition For Enhancing T-cell Function During Anti-tumor Response And Tumor-peptide Vaccination
App 20190070177 - Sotomayor; Eduardo M. ;   et al.
2019-03-07
Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination
Grant 10,016,421 - Sotomayor , et al. July 10, 2
2018-07-10
Histone deacetylase as a modulator of PDL1 expression and activity
Grant 9,987,258 - Villagra , et al. June 5, 2
2018-06-05
Selective histone deactylase 6 inhibitors
Grant 9,956,192 - Sotomayor , et al. May 1, 2
2018-05-01
Selective Histone Deactylase 6 Inhibitors
App 20170369428 - Sotomayor; Eduardo M. ;   et al.
2017-12-28
Bromodomain Inhibitor As Adjuvant In Cancer Immunotherapy
App 20170360801 - Sotomayor; Eduardo M. ;   et al.
2017-12-21
Selective histone deactylase 6 inhibitors
Grant 9,751,832 - Sotomayor , et al. September 5, 2
2017-09-05
Evidence-based Clinical Decision System
App 20170068789 - Dalton; William S. ;   et al.
2017-03-09
Histone Deacetylase 6 Inhibition For Enhancing T-cell Function During Anti-tumor Response And Tumor-peptide Vaccination
App 20170056402 - Sotomayor; Eduardo M. ;   et al.
2017-03-02
Histone Deacetylase As A Modulator Of Pdl1 Expression And Activity
App 20170049755 - VILLAGRA; Alejandro V. ;   et al.
2017-02-23
Selective Histone Deactylase 6 Inhibitors
App 20170035710 - Sotomayor; Eduardo M. ;   et al.
2017-02-09
Selective histone deactylase 6 inhibitors
Grant 9,409,858 - Sotomayor , et al. August 9, 2
2016-08-09
Selective Histone Deactylase 6 Inhibitors
App 20160185716 - Sotomayor; Eduardo M. ;   et al.
2016-06-30
Hdac Inhibitors, Alone Or In Combination With Btk Inhibitors, For Treating Nonhodgkin's Lymphoma
App 20150105409 - Quayle; Steven Norman ;   et al.
2015-04-16
Selective Histone Deactylase 6 Inhibitors
App 20150056213 - Sotomayor; Eduardo M. ;   et al.
2015-02-26
Flagellin-based adjuvants and vaccines
Grant 7,404,963 - Sotomayor , et al. July 29, 2
2008-07-29
Flagellin-based adjuvants and vaccines
App 20060088555 - Sotomayor; Eduardo M. ;   et al.
2006-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed